HISTalk
Loyal readers might recall I attended the inaugural HLTH Conference last year and, as I wrote here, came away pleasantly surprised. I eagerly returned to see how its second edition…
With over 20 HIMSS conferences, 10 Health Evolution Summits, and somewhere in-between as many times hanging out in Union Square for the JPMorgan Conference under my belt (not to mention…
With summer winding down and Labor Day in the rear view mirror, it felt like a good time to write a quick Investor’s Chair post and share one or two…
“CareCloud borrows $25.5 million from a growth capital lender. I’m never cheered by a company taking on debt just like I wouldn’t be thrilled about a relative signing up for…
“Mr H, can you get Ben Rooks to opine on how smart Wall Street types could pay $1B for a $450M transcription company? Greater fool theory or something sinister?” Sitting here…
Readers might recall my post two years ago that discussed several ways to capitalize a new venture. I’d like to use today’s post to discuss some of the root challenges…
With the benefit of hindsight, perhaps Vocera and its underwriters did underprice its IPO, but there’s no way to predict how a company will trade once it’s public. Recall that…
“My broker has found nothing other than the usual suspects and none of them are rated all that good. It would be interesting to have your investment banker dude weigh…
The tickets are bought, the hotel rooms booked, and the excitement is near. Time to start the HIMSS prep. Inquiring minds want to know – what do members of the…
RSNA is short for the annual meeting of the Radiological Society of North America. This year was its 96th Scientific Assembly and Annual Meeting. A long-time attendee (the late CEO…
